Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Dehydroevodiamine

Copy Product Info
🥰Excellent
Catalog No. T2S2335Cas No. 67909-49-3
Alias DHED

Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.

Dehydroevodiamine

Dehydroevodiamine

Copy Product Info
🥰Excellent
Purity: 99.54%
Catalog No. T2S2335Alias DHEDCas No. 67909-49-3
Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$35In StockIn Stock
10 mg$48In StockIn Stock
25 mg$77In StockIn Stock
50 mg$113In StockIn Stock
100 mg$166In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.54%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Dehydroevodiamine AI Summary
Dehydroevodiamine is a bioactive molecule known for its diverse pharmacological properties. It acts as an inhibitor of Cytochrome P450 enzymes with varying potencies: it has a moderate inhibitory effect on Cytochrome P450 1A1 (IC50 = 18050.0 nM), a stronger inhibition on Cytochrome P450 1A2 (IC50 = 5630.0 nM), and potent inhibition on Cytochrome P450 1B1 (IC50 = 330.0 nM), displaying higher selectivity towards P450 1B1. Additionally, Dehydroevodiamine demonstrates vasodilatory effects in rat thoracic aortic rings by inhibiting phenylephrine-induced contractions, with an EC50 range of 1600.0 nM to 7780.0 nM, depending on the experimental conditions. It also acts as an antagonist at the alpha-adrenoceptor with a dissociation constant (Kd) of 128.82 nM and can displace [3H]prazosin from the alpha1 adrenoceptor with a Ki of 2400.0 nM. The compound can displace [3H]8-OH-DPAT from the 5HT1A receptor with a K_i of 36000.0 nM. Its antiinflammatory activity is evident in IFN-gamma/LPS-stimulated mouse RAW264.7 cells, where it inhibits NO production, particularly when pre-treatment occurs before IFN-gamma stimulation. The antiinflammatory effects are dose-dependent, showing significant inhibition at 10 μM and retaining activity post-LPS addition, though less effectively than pre-stimulation treatment..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Dehydroevodiamine (DHED), a constituent of Evodia rutaecarpa, has various biological effects such as hypotensive, negative chronotropic, ion channel depressant, inhibition of nitric oxide production and cerebral blood flow enhancing activities.
SynonymsDHED
Chemical Properties
Molecular Weight301.34
FormulaC19H15N3O
Cas No.67909-49-3
SmilesC[n+]1c2-c3[n-]c4ccccc4c3CCn2c(=O)c2ccccc12
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 16.67 mg/mL (55.32 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Saline: 1 mg/mL (3.32 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3185 mL16.5926 mL33.1851 mL165.9255 mL
5 mM0.6637 mL3.3185 mL6.6370 mL33.1851 mL
10 mM0.3319 mL1.6593 mL3.3185 mL16.5926 mL
20 mM0.1659 mL0.8296 mL1.6593 mL8.2963 mL
50 mM0.0664 mL0.3319 mL0.6637 mL3.3185 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Dehydroevodiamine | purchase Dehydroevodiamine | Dehydroevodiamine cost | order Dehydroevodiamine | Dehydroevodiamine chemical structure | Dehydroevodiamine formula | Dehydroevodiamine molecular weight